Molecular modelling of subtypes (α2A, α2B and α2C) of α2-adrenoceptors: A comparative study

Neurochemistry International

Volumn 55, Issue 6, 2009, Pages 355-361

  Balogh, Balázs ^a   Szilágyi, András ^a   Gyires, Klára ^a   Bylund, David B ^b   Mátyus, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

2 Adrenoceptor; AutoDock; Binding free energy; Docking; Homology modelling; Subtype selectivity

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR;

ARTICLE; BINDING SITE; LIGAND BINDING; MATHEMATICAL COMPUTING; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTAGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BIOPHYSICS; CATTLE; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; LIGANDS; MODELS, MOLECULAR; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADRENERGIC, ALPHA-2; SOFTWARE;

BOVINAE;

EID: 67650096635     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.05.004     Document Type: Article

References (39)

1. 2A-adrenoceptor agonists. Chem. Med. Chem. 2 (2007) 801-805
2. Ballesteros J.A., and Weinstein H. Integrated methods for the construction of three dimensional models and computational probing of structure-function relationships in G-protein coupled receptors. Methods Neurosci. 25 (1995) 366-428
3. Berendsen H.J.C., van der Spoel D., and van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91 (1995) 43-56
4. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R., and Trendelenburg IV A.U. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46 2 (1994) 121-136
5. Carrieri A., and Fano A. The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models. Curr. Top. Med. Chem. 7 (2007) 195-205
6. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 (2003) 3497-3500
7. Crassous P.-A., Denis C., Paris H., and Senard J.M. Interest of α2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr. Top. Med. Chem. 7 (2007) 187-194
8. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, Palo Alto, CA, USA
9. Diemand A.V., and Scheib H. iMolTalk: an interactive, internet-based protein structure analysis server. Nucleic Acids Res. 32 (2004) 512-516
10. 2-adrenoceptor subtypes. Curr. Top. Med. Chem. 7 (2007) 163-186
11. Gasteiger J., and Marsili M. Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron 36 (1980) 3219-3228
12. 2C-subtype. J. Med. Chem. 47 (2004) 6160-6173
13. Guha R., Howard M.T., Hutchison G.R., Murray-Rust P., Rzepa H., Steinbeck C., Wegner J.K., and Willighagen E. The Blue Obelisk -- Interoperability in Chemical Informatics. J. Chem. Inf. Model. 46 (2006) 991-998
14. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Proceedings of the Nucleic Acids Symposium Series, vol. 41 (1999) 95-98
15. Henderson R., Baldwin J.M., Ceska T.A., Zemlin F., Backmann E., and Downing K.H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213 (1990) 899-929
16. Hendlich M., Rippmann F., and Barnickel G. LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. J. Mol. Graph. Model. 15 (1997) 359-363
17. Hetenyi C., Paragi G., Maran U., Timar Z., Karelson M., and Penke B. Combination of a modified scoring function with two-dimensional descriptors for calculation of binding affinities of bulky, flexible ligands to proteins. J. Am. Chem. Soc. 128 (2006) 1233-1239
18. Hooft R., Vriend G., Sander C., and Abola E. Errors in protein structures. Nature 381 (1996) 272
19. 35s]GTPγS binding. Biochem. Pharmacol. 55 (1998) 1035-1043
20. Kardos J., Yamamoto K., Hasegawa K., Naiki H., and Goto Y. Direct measurement of thermodynamic parameters of amyloid formation by isothermal titration calorimetry. J. Biol. Chem. 279 (2004) 55308-55314
21. Leavitt S., and Freire E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 11 (2001) 560-566
22. Lindahl E., Hess B., and van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 7 (2001) 306-317
23. Mehler E.L., and Solmayer T. Electrostatic effects in protein: comparison of dielectric and charges model. Prot. Eng. 4 (1991) 903-910
24. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comp. Chem. 19 (1998) 1639-1662
25. Nyronen T., Pihlavisto M., Peltonen J.M., Hoffren A.M., Varis M., Salminen T., Wurster S., Marjamaki A., Kanerva L., Katainen E., Laaksonen L., Savola J.M., Scheinin M., and Johnson M.S. Molecular mechanism for agonist-promoted a2Aadrenoceptor activation by norepinephrine and epinephrine. Mol. Pharmacol. 59 (2001) 1343-1354
26. Okada T., Sugihara M., Bondar N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure. J. Mol. Biol. 342 (2004) 571-583
27. Pedretti A., Villa L., and Vistoli G. Vega-an open platform to develop chemo-bio-informatics application, using plug-in architecture and script programming. J. Comput. Aided Mol. Des. 18 (2004) 167-173
28. 2A-adrenoceptor. Br. J. Pharmacol. 140 (2003) 347-358
29. Palczewiski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le T.I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
30. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., Schertler G.F., Weis W.I., and Kobilka B.K. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
31. Remko M., Walsh O.A., and Graham R.W. Molecular structure and gas-phase reactivity of clonidine and rilmenidine: two-layered ONIOM calculations. Phys. Chem. Chem. Phys. 3 (2001) 901-907
32. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
33. 2A-adrenergic receptor complexes provide a structural explanation for ligand binding. J. Biol. Chem. 274 (1999) 23405-23413
34. Schertler G.F.X., Villa C., and Henderson R. Projection structure of rhodopsin. Nature 362 (1993) 770-772
35. SYBYL 7.2, Tripos Inc., 1699 South Hanley Rd., St. Louis, MO, USA.
36. Teller D.C., Okada T., Behnke C.A., Palczewski K., and Stenkamp R.E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40 (2001) 7761-7772
37. 2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 129 (2007) 397-410
38. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40 (1991) 168-179
39. 2-adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands. J. Struct. Biol. 150 (2005) 126-143